Rationale for anticoagulant therapy of pulmonary fibrosis

Am J Respir Crit Care Med. 2014 Feb 1;189(3):362-3. doi: 10.1164/rccm.201305-0845LE.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anticoagulants / therapeutic use*
  • Female
  • Humans
  • Idiopathic Pulmonary Fibrosis / drug therapy*
  • Male
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Warfarin